Alan Olague

Discovery and optimization of oxadiazole-based FLAP inhibitors.

Asitha Abeywardane, J. M. Hutzler, A. Bartolozzi, 2017, Bioorganic & medicinal chemistry letters.

Substituted 2H-isoquinolin-1-ones as potent Rho-kinase inhibitors: part 3, aryl substituted pyrrolidines.

Xiang Li, Eugene R. Hickey, Steven Kerr, 2010, Bioorganic & medicinal chemistry letters.

Synthesis, SAR, and series evolution of novel oxadiazole-containing 5-lipoxygenase activating protein inhibitors: discovery of 2-[4-(3-{(r)-1-[4-(2-amino-pyrimidin-5-yl)-phenyl]-1-cyclopropyl-ethyl}-[1,2,4]oxadiazol-5-yl)-pyrazol-1-yl]-N,N-dimethyl-acetamide (BI 665915).

M. Hao, Asitha Abeywardane, T. Morwick, 2015, Journal of medicinal chemistry.

PDE-10A inhibitors as insulin secretagogues.

Lei Zhu, J. Livingston, T. Claus, 2007, Bioorganic & medicinal chemistry letters.